Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Construction in Progress (2009 - 2024)

Updated

Sinovac Biotech (SVA) posted Construction in Progress of $1.65 trillion for Q4 2012, down 92.6% from $22.34 trillion a year earlier.

Analysis

Sinovac Biotech (SVA) Construction in Progress (2009 - 2024) Analysis & Trends

  • In prior years, Sinovac Biotech's Construction in Progress was $22.34 trillion in FY2011.
  • The Q4 2012 figure stands as the lowest quarterly Construction in Progress since Q3 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Sinovac Biotech 464.94 Mn -24.98 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 178.95 Mn
Dec 31, 2023 146.81 Mn
Dec 31, 2022 327.78 Bn
Dec 31, 2021 166.17 Mn
Dec 31, 2012 1,645.89 Bn
Dec 31, 2011 22,341.63 Bn
Sep 30, 2009 823,860.00
API Access

Sinovac Biotech Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=SVA&period=max&api_key=YOUR_API_KEY